Raymond Sisk
Acute Care · Sikeston, MONPI 1699067645
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by GSK at 25.4% of the total. Reporting peaked in 2021 at $1,099 and has fallen 97.3% since, to $30 in 2025.
Across 109 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$419
- AstraZeneca$260
- Mylan Specialty L.p.$228
- Grifols USA, LLC$78
- Sanofi$74
- AbbVie$71
- plus $522 from 16 others
What the payments were for
- Food & beverage$1,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 36 | $419 |
| AstraZeneca | 14 | $260 |
| Mylan Specialty L.p. | 13 | $228 |
| Grifols USA, LLC | 5 | $78 |
| Sanofi | 4 | $74 |
| AbbVie | 4 | $71 |
| Merck | 4 | $61 |
| Electromed, Inc. | 6 | $60 |
| Novo Nordisk | 4 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Advanced Respiratory, Inc | 1 | $34 |
| Eisai Inc. | 2 | $32 |
| La Jolla Pharmaceutical Company | 1 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$1,653 in reported general payments places this provider in the 80th percentile of 272 acute care providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 77 | $49,066 |
| EliquisApixaban | 31 | $9,832 |
| EntrestoSacubitril/Valsartan | 23 | $8,580 |
| FarxigaDapagliflozin Propanediol | 21 | $8,505 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,417 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,282 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $917 |
| Cephalexin | 56 | $553 |
| Levothyroxine Sodium | 44 | $444 |
| Azithromycin | 146 | $440 |
| Ondansetron Hcl | 29 | $345 |
| Diclofenac Sodium | 29 | $339 |
| Doxycycline Hyclate | 30 | $315 |
| Tamsulosin Hcl | 13 | $291 |
| Hydroxyzine Hcl | 16 | $275 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $419 | $49,06677 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $260 | $16,92234 claims |
| Boehringer IngelheimStiolto Respimat | $27 | $6,28213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 272 acute care providers in Missouri.
Other acute care in Sikeston
- Molly CahillKansas City$22K
- Kristin PressChesterfield$14K
- Sarah HeaveyKansas City$9K
- Nedra HarringtonPotosi$8K
- Hunter SmithColumbia$7K
- Heather UelhofO Fallon$6K
- Caroline MundhenkeKansas City$6K
- Jennifer ReganSaint Louis$5K
- Jena SchollCape Girardeau$5K
- Kayla TourvilleSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.